Hosted by Prof. Eduardo Eyras, Director of the Shine-Dalgarno Centre for RNA Innovation (SDCRI), Oliver Distler, Director of Business Development at Syngenis Labs Ltd, visited SDCRI on 15 September 2026 to present the company’s capabilities and discuss the SDCRI researchers’ needs for antisense oligonucleotides (ASOs), splice-switching oligonucleotides (SSOs), and RNA/DNA oligonucleotide development.